Showing results (611-620 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|August 6, 2010
Nutlin-1 strengthened anti-proliferation and differentiation-inducing activity of ATRA in ATRA-treated p-glycoprotein deregulated human myelocytic leukemia cellsLei Zhang, Yan Yan, Difeng Zhu, et al.
Investigational New Drugs|August 6, 2010
Protoapigenone, a natural derivative of apigenin, induces mitogen-activated protein kinase-dependent apoptosis in human breast cancer cells associated with induction of oxidative stress and inhibition of glutathione S-transferase πWen-Ying Chen, Yu-An Hsieh, Ching-I Tsai, et al.
Investigational New Drugs|August 11, 2010
A phase I dose escalation study of TTI-237 in patients with advanced malignant solid tumorsAndrea Wang-Gillam, Susanne M Arnold, Ronald M Bukowski, et al.
Investigational New Drugs|August 11, 2010
Phase I study of gemcitabine, docetaxel and imatinib in refractory and relapsed solid tumorsBiren Saraiya, Rashmi Chugh, Vassiliki Karantza, et al.
Investigational New Drugs|August 17, 2010
A phase II study of tandutinib (MLN518), a selective inhibitor of type III tyrosine receptor kinases, in patients with metastatic renal cell carcinomaDale R Shepard, Matthew M Cooney, Paul Elson, et al.
Investigational New Drugs|August 17, 2010
Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinomaAna M Molina, Darren R Feldman, Michelle S Ginsberg, et al.
Investigational New Drugs|August 31, 2010
Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II ConsortiumHedy Lee Kindler, Kristen Wroblewski, James A Wallace, et al.
Investigational New Drugs|September 3, 2010
A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumorShih-Hung Yang, Chia-Chi Lin, Zhong-Zhe Lin, et al.
Investigational New Drugs|June 5, 2010
Dequalinium induces apoptosis in peripheral blood mononuclear cells isolated from human chronic lymphocytic leukemiaLucia Pajuelo, Eva Calviño, Jose Carlos Diez, et al.
Investigational New Drugs|September 16, 2010
A comparison of the pharmacokinetics of the anticancer MET inhibitor foretinib free base tablet formulation to bisphosphate salt capsule formulation in patients with solid tumorsAung Naing, Razelle Kurzrock, Laurel M Adams, et al.
Pageof 372